HAN Zhigang, YU Tingting, SHEN Hongli, Alimjan Saitiwaerdi. Study on the correlation of Napsin-A expression and EGFR genes in non-small cell lung cancer tissue[J]. Journal of Clinical Medicine in Practice, 2014, (13): 1-3. DOI: 10.7619/jcmp.201413001
Citation: HAN Zhigang, YU Tingting, SHEN Hongli, Alimjan Saitiwaerdi. Study on the correlation of Napsin-A expression and EGFR genes in non-small cell lung cancer tissue[J]. Journal of Clinical Medicine in Practice, 2014, (13): 1-3. DOI: 10.7619/jcmp.201413001

Study on the correlation of Napsin-A expression and EGFR genes in non-small cell lung cancer tissue

More Information
  • Published Date: September 10, 2014
  • Objective To explore the relationship between Napsin-A expression and epider-mal growth factor receptor (EGFR)genes in non-small cell lung cancer (NSCLC)tissue.Methods Napsin-A expression in 89 adenosquamous carcinoma tissues of the lung was detected by immunohisto-chemistry,and the expression of EGFR genes in the tissues above was also detected by ARMS kit.The relationship between Napsin-A expression and EGFR was analyzed.Results The Napsin-A positive rates of adenocarcinoma and squamous carcinoma in NSCLC tissue were 96.2% and 5.6%,respec-tively,and there was statistical significance between them.The mutation rate of EGFR gene in lung adenocarcinoma tissue was 54.7%,while that of the patients with positive Napsin-A expression came up to 100.0%.The mutation rate of EGFR gene in lung squamous tissue was 5.6%,while that of the patients with positive Napsin-A expression came up to 50.0%,in which significant difference was presented by comparison to them.Conclusion Napsin-A is highly expressed in lung adenocarcinoma tissue,and the EGFR mutation rate of patients with positive expression in adenosquamous carcinoma is also high.Hence,for the patients with positive Napsin-A expression,it should be recommended to de-tect EGFR genes.
  • Yamashita Y, Nagasaka T, Naiki-Ito A. Napsin A is a specific marker for ovarian clear cell adenocarcinoma [J]. Modern Pathology, 2014.
    Aulakh K S, Chisholm C D, Smith D A. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas:proposal of a novel staining panel [J]. ARCHIVES OF PATHOLOGY AND LABORATORY MEDICINE, 2013(8):1094.
    Oh M J, Choi J H, Kim I H. Detection of epidermal growth f actor receptor in the serum of patients with cervical carcinoma [J]. Clinical Cancer Research, 2000, (12):4760.
    李连弟, 鲁凤珠, 张思维. 中国恶性肿瘤死亡率 20 年变化趋势和近期预测分析 [J]. 中华肿瘤杂志, 1997(1):3.
    Turner B M, Cagle P T, Sainz I M. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma:evalua-tion of 1674 cases by tissue microarray [J]. ARCHIVES OF PATHOLOGY AND LABORATORY MEDICINE, 2012(2):163.
    Schauer-Vukasinovic V, Langen H, Giller T. Detection of im-munoreactive napsin A in human urine [J]. Biochimica et Biophysica Acta, 2001(1):51.
    Lim S H, Lee J Y, Sun J M. Comparison of clinical out-comes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21 [J]. JOURNAL OF THORACIC ONCOLOGY, 2014(4):506.
    Hwang K E, Kwon S J, Kim Y S. Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790Mmutation of EGFR [J]. Experimental Cell Research, 2014(2):288.
  • Cited by

    Periodical cited type(3)

    1. 王娟,郭潍宁,陆小莉,章馨,陶云,沈薛. 妊娠期胎动监测与胎动减少管理最佳证据总结. 全科护理. 2024(17): 3169-3175 .
    2. 姚娟娟,黄秀霞,岳智慧,邓瑾微. 导乐联合哀伤护理在围产期丧失产妇护理中的应用效果. 中国社区医师. 2023(32): 142-144 .
    3. 程彩霞. 单胎妊娠晚期胎死宫内的病因分析与预防策略. 实用妇科内分泌电子杂志. 2023(35): 47-49 .

    Other cited types(0)

Catalog

    Article views (346) PDF downloads (1) Cited by(3)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return